Shionogi Europe

From the United Nations to the G7, antimicrobial resistance (AMR) has rightly been in the global health spotlight at many high-level meetings this year. At Shionogi we continue to focus our efforts on helping to address the urgent crisis of drug-resistant infection, through our scientific research and advocating for sustainable policy solutions. Recently, we worked with Euractiv on a Shionogi-supported special report to highlight some of the challenges we must face together to help tackle AMR - "Antimicrobial resistance fight needs more ambition, new alliances and strategies". We covered these three important areas in the report: • Dr Isao Teshirogi, President & CEO of Shionogi, highlights the urgent need for new antibiotics and the economic challenges in R&D. • Simona Falciai, General Manager of Shionogi Italia, shares insights after the G7 Health Ministers’ meeting, where Italy’s Minister of Health, Professor Orazio Schillaci, pledged to tackle market failures in AMR. • At the #EuropeanHealthSummit, Huw Tippett, CEO of Shionogi Europe, calls for a rethink of antibiotics business models. Find out more in the full Euractiv report here: https://lnkd.in/eh6mBM4B #AMR #GlobalHealth #Innovation  #PublicHealth #G7 #AMRHLM

Huw Tippett, CEO of Shionogi Europe, took part in a panel discussion at the recent European Health Summit (EHS) in Brussels, which focused on the challenge of tackling antimicrobial resistance (AMR). During the discussion, he emphasised the need to rethink antibiotic business models by prioritising responsible use over sales volume. Huw shared insights from a successful pilot programme in the UK, which delinks revenue from sales, safeguarding essential antibiotics for appropriate use while supporting sustainable investment for companies involved in innovative antimicrobial R&D. In the latest article from a Shionogi-supported Euractiv special report - "The Fight Against Antimicrobial Resistance Needs More Ambition, New Alliances, and Strategies" - we hear from leading voices who shared their thoughts on the challenge of drug-resistant infection at the EHS meeting . AMR continues to pose a significant global health threat and needs immediate, collective action. At Shionogi, we are committed to being part of the solution through innovation and collaboration. Read more in the article - https://lnkd.in/eytXfCGn

This week’s European Health Summit in Brussels is an important opportunity for leaders to come together to shape the healthcare agenda. Leading representatives from across the healthcare industry, civil society, academia, and the business sector will engage with policymakers to explore the most pressing issues affecting the health of our societies. Today, our Chief Executive Huw Tippett will be discussing how the new EU legislative term provides an opportunity to focus our collective efforts on the important issue of drug-resistant infection as part of a panel discussion - "The EU’s Global Call: Fighting AMR for a Resilient Tomorrow".  We need to ensure we have sustainable antimicrobial pipelines, robust anti-infective stewardship and equitable access to diagnostics and medicines. We are committed to playing our part in helping combat this urgent health threat and look forward to positive discussions on how we can work together for a healthier future. #OneHealth #EuropeanHealthSummit2024 #AMR #AntimicrobialResistance

Meet the Shionogi Team at DIVI Congress 2024 held from December 4–6, 2024 in Hamburg! We’re looking forward to engaging with the brightest minds in the field of infectious diseases at the 24th DIVI Congress  and exploring how together, we can effectively and sustainably prevent and combat bacterial resistance! Let’s connect, collaborate, and innovate! 📍 Visit us at Booth HB-03, Congress Center Hamburg (CCH) to meet our German team on-site. #AMR # Innovation #Collaboration #DIVI2024

I had the pleasure of attending the "Access to Antibiotics in the Nordic Region" conference, which took place on November 25-26, 2024, in the beautiful historical venue of Uppsala Castle, Sweden. Hosted by the Swedish Medical Products Agency and supported by the Nordic Council of Ministers, this event focused on tackling Antimicrobial Resistance (#AMR) from a #OneHealth perspective. It brought together experts from industry, academia, healthcare, and regulatory bodies to address shared challenges and foster collaboration across human, animal, and environmental health sectors. Nordic countries face unique challenges related to their small antibiotic markets, which can result in antibiotic withdrawals or delayed launches. I was pleased to witness a wide range of stakeholders recognizing this challenge as a top priority and acknowledging that improving access will have an immediate impact on patient lives. Their recognition of the need for change and their determination to address this issue were inspiring. As someone who faces this challenge directly in my business, I am eager to continue the dialogue and work collaboratively on finding solutions. Shionogi is fully committed to contributing to the development of sustainable solutions. Warren Cowell

Often called the ‘silent epidemic’, antimicrobial resistance (AMR) is a health threat that could directly impact any of us and happens when infections become harder to manage as bacteria, viruses, fungi, and parasites no longer respond to the medicines designed to treat them. It’s one of the biggest public health threats we face today. Since Alexander Fleming discovered penicillin nearly 100 years ago, we have had effective antibiotics, which are now the building blocks of modern medicine. Without them, almost all medical procedures would become extremely risky, if not impossible, impacting everything from C-sections, to transplants, hip replacements and chemotherapy. This week, the World Health Organization invites us all to ‘Educate. Advocate. Act now’ to help tackle drug-resistant infection: Educate: Spread awareness about AMR by sharing information with friends, family and communities. Educating people about the appropriate use of antibiotics and the consequences of AMR can help prevent its spread. Advocate: Advocate for policies and practices that promote innovation and responsible use of antibiotics in healthcare and agriculture. Encourage Healthcare Providers to only subscribe antibiotics when necessary and raise awareness about the impact of AMR on public health. Act now: Take proactive steps by using antibiotics responsibly, promoting good hygiene, and supporting global initiatives aimed at addressing AMR. By taking action now, we can contribute to the fight against AMR and protect the effectiveness of antibiotics for future generations. Together, we can help slow the spread of AMR. #AMR #WorldAMRAwarenessWeek #GlobalHealth #PublicHealth #EducateAdvocateAct

Ahead of World AMR Awareness Week, we asked a group of bright young roving reporters from across Europe to share their thoughts on antimicrobial resistance (AMR). In their own words, they discuss ‘superbugs’, AMR, and how they believe we can shape the future of healthcare. By the time these children grow up, infections that are easy to treat today could once again become deadly unless we take action now. Hear what these young minds have to say about why we need to urgently pay attention to drug-resistant infection. Protecting our future health starts now — Educate. Advocate. Act now. #WorldAMRAwarenessWeek #AMR #Superbugs #FutureOfHealthcare #EducateAdvocateAct #GlobalHealth #AntimicrobialResistance

Last week, we proudly hosted a flagship event in Berlin in partnership with the German Network against AMR (DNAMR). This gathering brought together compelling voices from policy, healthcare, and innovation to foster meaningful dialogue and inspire collective solutions to combat antimicrobial resistance (AMR). In this article, we highlight the key insights gained from this special event and discuss how global collaboration can help us make progress in addressing the health threat posed by AMR.

Our collective overuse, and misuse, of antibiotics has accelerated the natural ability of certain bacteria, sometimes called ‘superbugs’, to adapt and resist the effects of the drugs designed to kill them. Every year, around 79 000 people lose their lives due to resistant infections across 34 OECD and EU/EEA countries. This is more than twice the number of deaths recorded in 2020 due to tuberculosis, influenza and HIV/AIDS combined¹. As latest predictions show that by 2050, deaths associated with antimicrobial resistance (AMR) could rise significantly, the data stacks up to show how this ‘silent epidemic’ issue needs our attention now². Find out more about how Shionogi is helping to tackle AMR at https://lnkd.in/eUFd6a2Y #WorldAMRAwarenessWeek #AMR #AntimicrobialResistance #EducateAdvocateActNow #GlobalHealth 1 Embracing a One Health Framework to Fight Antimicrobial Resistance | OECD 2 Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 - The Lancet

This World AMR Awareness Week we are adding our voice to the call for global action to tackle the urgent health issue of antimicrobial resistance (AMR). We need to educate, advocate and act now, together. In Defending our Health: Unravelling Antimicrobial Resistance - a Shionogi funded news-style programme produced by ITN Business – our CEO, Huw Tippett, and Head of Scientific Affairs, Andreas Karas, MD spoke about the actions we’re taking to ensure sustainable innovation and access to antimicrobials to help combat AMR. Watch the film about our work below and find out more about how we are tackling AMR here: https://lnkd.in/e-KcCs95 #AMR #AntimicrobialResistance #GlobalHealth #WorldAMRAwarenessWeek #CollectiveStrength #EducateAdvocateActNow